Meghan Caitlin Thompson MD
Hematology/Oncology
Assistant Attending, Leukemia Service, Memorial Sloan Kettering Cancer Center
136 Mountain View BoulevardBasking Ridge, NJ 07920
Overview of Dr. Thompson
Meghan Thompson, MD is an Internal Medicine specialist who resides in New York, NY. She has a subspecialty in Hematology/Oncology and is experienced with hematologic malignancies, clinical research, Richter’s transformation, and treating B-cell chronic lymphocytic leukemia. She completed her Hematology and Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center, Residency in Internal Medicine at University of Pennsylvania Health System, and graduated as a part of Ohio State University College of Medicine's Class of 2016. Dr. Thompson has published multiple papers in leading journals, with one of her papers being cited 23 times. She has a foundational education in economics from Princeton University.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
University of Pennsylvania Health SystemResidency, Internal Medicine, 2016 - 2019
Ohio State University College of MedicineClass of 2016
Princeton UniversityA.B., Economics, 2007 - 2011
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 2020 - 2027
PA State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs.Hannah Burton, Leora Boussi, David Nemirovsky, Andriy Derkach, Jenna Ciervo
Cancer. 2025-08-15 - Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia.Allison Kagerer, Meghan C Thompson
Hematology/oncology Clinics of North America. 2025-07-16 - BTK Inhibitors Versus Venetoclax as First- or Second-Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Evidence Study.Lindsey E Roeker, Yi Han, Anna Teschemaker, Anthony R Mato, Meghan C Thompson
American Journal of Hematology. 2025-04-01
Press Mentions
How to Manage Venetoclax Resistance in Chronic Lymphocytic LeukemiaJune 23rd, 2021- Triple Therapy for CLL Shows Promise in Phase 2 TrialSeptember 21st, 2020
- MSK Research Highlights, February 12, 2024February 13th, 2024
Research History
- Research AssistantCenter for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital2011 - 2013
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
